Annual Cash & Cash Equivalents
$1.95 M
+$1.58 M+423.92%
December 31, 2023
Summary
- As of February 8, 2025, CLDI annual cash & cash equivalents is $1.95 million, with the most recent change of +$1.58 million (+423.92%) on December 31, 2023.
- During the last 3 years, CLDI annual cash & cash equivalents has risen by +$1.53 million (+364.05%).
- CLDI annual cash & cash equivalents is now -8.80% below its all-time high of $2.14 million, reached on December 1, 2021.
Performance
CLDI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.90 M
+$1.06 M+126.91%
September 30, 2024
Summary
- As of February 8, 2025, CLDI quarterly cash and cash equivalents is $1.90 million, with the most recent change of +$1.06 million (+126.91%) on September 30, 2024.
- Over the past year, CLDI quarterly cash and cash equivalents has dropped by -$8.25 million (-81.30%).
- CLDI quarterly cash and cash equivalents is now -81.30% below its all-time high of $10.15 million, reached on September 30, 2023.
Performance
CLDI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CLDI Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +423.9% | -81.3% |
| 3 y3 years | +364.1% | -81.3% |
| 5 y5 years | +364.1% | -81.3% |
CLDI Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.8% | +423.9% | -81.3% | +848.5% |
| 5 y | 5-year | -8.8% | +423.9% | -81.3% | +848.5% |
| alltime | all time | -8.8% | +423.9% | -81.3% | +848.5% |
Calidi Biotherapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.90 M(+126.9%) |
| Jun 2024 | - | $836.00 K(-26.9%) |
| Mar 2024 | - | $1.14 M(-41.4%) |
| Dec 2023 | $1.95 M | $1.95 M(-80.8%) |
| Sep 2023 | - | $10.15 M(+429.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $1.92 M(+415.6%) |
| Dec 2022 | $372.00 K(-82.6%) | - |
| Dec 2022 | - | $372.00 K(+86.0%) |
| Sep 2022 | - | $200.00 K(-90.6%) |
| Dec 2021 | $2.14 M(+408.8%) | $2.14 M |
| Dec 2020 | $420.00 K | - |
FAQ
- What is Calidi Biotherapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Calidi Biotherapeutics?
- What is Calidi Biotherapeutics annual cash & cash equivalents year-on-year change?
- What is Calidi Biotherapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Calidi Biotherapeutics?
- What is Calidi Biotherapeutics quarterly cash and cash equivalents year-on-year change?
What is Calidi Biotherapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CLDI is $1.95 M
What is the all time high annual cash & cash equivalents for Calidi Biotherapeutics?
Calidi Biotherapeutics all-time high annual cash & cash equivalents is $2.14 M
What is Calidi Biotherapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CLDI annual cash & cash equivalents has changed by +$1.58 M (+423.92%)
What is Calidi Biotherapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CLDI is $1.90 M
What is the all time high quarterly cash and cash equivalents for Calidi Biotherapeutics?
Calidi Biotherapeutics all-time high quarterly cash and cash equivalents is $10.15 M
What is Calidi Biotherapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CLDI quarterly cash and cash equivalents has changed by -$8.25 M (-81.30%)